One test to diagnose all: In this guest editorial, Neil Ward, VP of PacBio EMEA, explores why current diagnostic pathways for rare diseases are falling short
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening
GutID is the first microbiome test able to identify all bacteria in the gut at the strain level and could help manage and prevent a wide range of diseases
As scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease
See how the secrets of the genome and emerging gene editing technologies are revolutionizing life sciences research
By combining Intus Bio’s strain-level resolution assay and AI-powered analysis with PacBio’s sequencing accuracy, GutID sets a new benchmark in gut microbiome testing.
Study shows PacBio's HiFi long-read sequencing can identify genetic causes of rare diseases, potentially simplifying diagnostics
Highly accurate long-read sequencing data from Revio will support Germany’s National Genome Initiative and provide data to the International Male Infertility Consortium
Explore how PacBio’s advanced HiFi sequencing technology is driving new insights into genetic diversity, disease mechanisms, and clinical diagnoses within Singapore’s diverse multi-ethnic population
